TickerFacts.

Immix Biopharma, Inc. (IMMX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

32.97M
Year ended 2025-12-31
+33.4%
3-year compound annual growth
2022-12-31: 13.89M2023-12-31: 17.34M2024-12-31: 28.29M2025-12-31: 32.97M32.97M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3132.97M+16.5%2026-03-27, From 2025-01-01
2024-12-3128.29M+63.1%2026-03-27, From 2024-01-01
2023-12-3117.34M+24.9%2025-03-25, From 2023-01-01
2022-12-3113.89Mn/a2024-03-29, From 2022-01-01